ARCHIVES

Unorthodox Panel Considers NIH Mandated Role In Study of Unconventional Medical Practices

This article is from The Cancer Letter archive.

Vol. 18 No. 26 | June 26, 1992

Download PDF Visit The Full Archive

Related Articles

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

Funding Opportunities

January 17, 2003

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

Prime Contract Subcontract Opportunities

January 24, 1975

DePinho Apologizes For Investment Advice: On CNBC He Recommended A Firm He Founded

June 1, 2012

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012